40
13 - 15 AUGUST 2018 ADELAIDE CONVENTION CENTRE @ASHMMEDIA | #VH18 CONFERENCE HANDBOOK 11 TH AUSTRALASIAN CONFERENCE NO ONE LEFT BEHIND
1
1 3 - 1 5 AU G U ST 2 0 1 8ADEL AIDE CONVENTION CENTRE
@A S H M M E D I A | # V H 1 8
CO N F E R E N C E H A N D B O O K
1 1 T H AU ST RA L AS I A N CO N F E R E N C E
N O O N E L E F T B E H I N D
Platinum Sponsor
Silver Sponsor
Destination Supporter
Bronze Sponsor
M A J O R S PO N S O RS & S U P PO RT E RS
CO L L A B O RAT I N G O R G A N I SAT I O N S
THANK YOU TO OUR SPONSORS & SUPPORTERS
CONTENTS
Invited Speakers u 3
Floor Plans and Maps u 6
Exhibition Directory u 8
Program u 11
Poster Listing u 31
1
CO N F E R E N C E E N V I RO N M E N T PO L I C Y
ASHM Conference and Events Division implements a waste-reduction policy that addresses:
• Reduce, Reuse, Recycle. This is done before, during and after each conference.
• ASHM Conference & Events Division reduces the number of printed materials by using electronic communication means wherever possible, including the website, email, online registration and abstract submission.
• ASHM Conference & Events Division monitors final delegate numbers for an accurate forecast of catering requirements in order to avoid waste.
• ASHM Conference & Events Division aims to research and prioritise purchasing items and equipment that support the use of recycled materials or can be recycled after use.
• ASHM Conference & Events Division will aim to ensure that recycling bins are available onsite at all events.
• ASHM Conference & Events Division will endeavor to minimise travel through the use of teleconferences instead of face-to-face meetings and holding meetings only when necessary.
ASHM Conference & Events Division encourages all conference stakeholders to consider the environment by suggesting the following: reduction in printing requirements; recycling conference materials; and reusing conference merchandise.
N AT I O N A L O F F I C E
A Locked Mail Bag 5057 Darlinghurst NSW 1300, Australia
T +61 2 8204 0770
W www.ashm.org.au
ABN: 48 264 545 457
CFN: 17788
© ASHM 2018
Design and layout by Rachel Lincoln
Printed by TTR Print Management
2
PROUDLY SUPPORTED BY
3
PROUDLY SUPPORTED BY
I N T E R N AT I O N A L S P E A K E RS
LO C A L S P E A K E RS
MEHLIKA TOYPhD, DSc, Stanford University School of Medicine, USA
ANDREW LLOYDProfessor, Program Head, Viral Immunology Systems Program (VISP), The Kirby Institute, UNSW Sydney
KATHRYN LEAFEExecutive Director, New Zealand Needle Exchange Programme, New Zealand
MICHAEL NINBURGPresident, World Hepatitis Alliance, USA
GAIL MATTHEWSAssociate Professor, Viral Hepatitis Clinical Research Program, The Kirby Institute, UNSW Sydney
SUNIL SOLOMON Associate Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA
KYLIE VALENTINE Associate Professor, Social Policy Research Centre, UNSW Sydney
4
Dr Jones & Partners is able to provide Elastography Ultrasound scans at many of our clinics located Centrally, North, South and Hills.
For bookings contact the nearest Dr Jones & Partners Medical Imaging Clinic.
For further information on Liver Elastography scans please contact the Radiologist at your nearest Dr Jones & Partners clinic or visit our website www.drjones.com.au
Assessment and Management of Liver Fibrosis and CirrhosisDr Jones & Partners is able to provide Liver Elastography scans (a non-invasive, ultrasound scan). This scan can help accurately assess patients with minimal fibrosis or with severe fibrosis/cirrhosis.
Several new medications have been made available on the PBS for the treatment of patients with Hepatitis C. These medications enable GPs to effectively treat and manage affected patients to minimise liver damage.
Elastography of the liver can be referred for both the initial assessment of disease (baseline) and
monitoring of response to treatment (progression/response).
An Elastography Ultrasound scan is Medicare rebated. It can be referred by both GPs
and Specialists.
Elastography is used for the initial assessment and ongoing management of patients with:
• Hepatitis B• Hepatitis C• Chronic liver disease• Liver fibrosis• History of heavy alcohol use/abuse• Potential cirrhosis from non-alcoholic
fatty liver disease.
The referring clinician should request “Liver Elasto” - one of the clinical indications above should be detailed on the referral form.
Patient Preparation - Standard preparation for an Upper Abdominal Ultrasound. Patients are required to fast for 6 hours prior to the exam.
Metavir Fibrosis Stages
F0No fibrosis
F1Slight
fibrosis
F2Moderate
fibrosis
F3Significant
fibrosis
F4Cirrhosis
drjones.com.auDoctor Led • Patient Focused • Quality Driven
ULTRASOUND ELASTOGRAPHY
5
The conference app is the best way to stay informed during the conference and it’s free to download.
W H AT CA N I D O W I T H T H E A P P?
• View the program by session or time, read the abstracts and let others know what you think about the session by sharing it on twitter
• Answer polling questions during presentations
• Search for speakers, read their bio and see what presentations they are giving
• View a list of all the sponsors and exhibitors and check where they’re located
• Send a direct message to that person you have been trying to pin down for a meeting
H O W D O I G ET T H E A P P?
The Conference App is available to download from the Apple app store or Google Play Simply search for ‘Events App by EventsAIR’.
H O W D O I LO G I N TO T H E A P P?
Once you have found the app in your App Store:
1. Install the App.
2. The first time you open the app, you will need to enter the event code: VH2018
3. To login, enter your primary email address and pin (which you received in your app instructions email and final registration confirmation email).
W I - F I D ETA I L S
Connect to: VIRALHEP18
Password: VIRALHEP18
Dr Jones & Partners is able to provide Elastography Ultrasound scans at many of our clinics located Centrally, North, South and Hills.
For bookings contact the nearest Dr Jones & Partners Medical Imaging Clinic.
For further information on Liver Elastography scans please contact the Radiologist at your nearest Dr Jones & Partners clinic or visit our website www.drjones.com.au
Assessment and Management of Liver Fibrosis and CirrhosisDr Jones & Partners is able to provide Liver Elastography scans (a non-invasive, ultrasound scan). This scan can help accurately assess patients with minimal fibrosis or with severe fibrosis/cirrhosis.
Several new medications have been made available on the PBS for the treatment of patients with Hepatitis C. These medications enable GPs to effectively treat and manage affected patients to minimise liver damage.
Elastography of the liver can be referred for both the initial assessment of disease (baseline) and
monitoring of response to treatment (progression/response).
An Elastography Ultrasound scan is Medicare rebated. It can be referred by both GPs
and Specialists.
Elastography is used for the initial assessment and ongoing management of patients with:
• Hepatitis B• Hepatitis C• Chronic liver disease• Liver fibrosis• History of heavy alcohol use/abuse• Potential cirrhosis from non-alcoholic
fatty liver disease.
The referring clinician should request “Liver Elasto” - one of the clinical indications above should be detailed on the referral form.
Patient Preparation - Standard preparation for an Upper Abdominal Ultrasound. Patients are required to fast for 6 hours prior to the exam.
Metavir Fibrosis Stages
F0No fibrosis
F1Slight
fibrosis
F2Moderate
fibrosis
F3Significant
fibrosis
F4Cirrhosis
drjones.com.auDoctor Led • Patient Focused • Quality Driven
ULTRASOUND ELASTOGRAPHYCO N F E R E N C E A P P
6
V E N U E F LO O R P L A N
Plenary
Exhibition, Posters and Catering
Breakout rooms
Speakers Preparation Room
Auxiliary Meeting Room
GROUND FLOOR
LEVEL ONE
7
E X H I B I T I O N F LO O R P L A N
Lounge/Café Seating
Promo Table
Entrance
2
14
8
3
7
6
5
8
E X H I B I T I O N D I R EC TO RY
Booth number: 2
ADDRESSING SOME OF THE WORLD’S GREATEST HEALTH NEEDS
AbbVie is a biopharmaceutical company that has been in Australia for more than 75 years and is focused on developing new products and new ways to help people manage their health, and lead better lives. We tackle diseases where there is a significant need for better solutions and we come together every day to create, discover and deliver new ways to improve people’s health and wellness in the areas of hepatitis C, immune-mediated conditions, neuroscience and oncology. Website link: www.abbvie.com.au.
Booth number: 1
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) is a peak professional society representing a multidisciplinary health workforce –comprising membership of over 1500. ASHM manages accreditation programs for community prescribing of s100 medications; also providing education to health workers supporting HIV, hepatitis B and C patients.
Booth number: 4
Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, in fields such as critical and healthcare-associated infections, sexual health, genetic diseases and cancer.
Booth number: 6
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
9
Booth number: 3
2018/19 will see new Fibroscan probe enhanced measuring and steatosis parameter upgrades to further improve accuracy, this will be available on recent models 430/530. If you have an older FS402, upgrading to FS430/530 processor is the best option with probes post 2012. Steatosis CAP is sometimes overlooked, it often influences stiffness. MTA is applying for a new MSAC rebate for HCV and HBV.
Booth number: 5
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
Booth number: 8
Established for over 10 years, the Australasian Hepatology Association (AHA) is the peak professional body supporting and educating hepatology nurses and allied health professionals across Australia and New Zealand. Our membership consists of well-informed forward-thinking and experienced Hepatology professionals who encompass many specialist areas in a variety of settings. These include Hepatitis B and C treatment and care, chronic liver disease and chronic disease management, liver transplantation, liver cancer, health policy, sexual health, mental health, drug and alcohol, infectious diseases, indigenous health, culturally and linguistically diverse (CALD) health services, prison health services and nutrition.
Booth number: 7
Hepatitis Australia is the national peak community organisation to progress action on issues of importance to people affected by hepatitis B and hepatitis C. Our members are the eight state and territory hepatitis organisations. Our mission is to lead an effective national community response to hepatitis B and hepatitis C in Australia and realise our vision to see an end to hepatitis B and C in Australia. We work to improve health and social outcomes for all Australians who are at risk of or living with hepatitis B or C and pay particular attention to those groups which are at higher risk of infection or have a disproportionate burden of chronic disease.
1 0
1 1
MO
ND
AY,
13
AU
GU
ST
20
18
7.30
amR
egis
trat
ion
Ope
ns
8.30
am -
11
.00a
mO
peni
ng P
lena
ry 1
Room
: Hal
l M | C
hairs
: Mel
anie
Wal
ker a
nd S
amue
l Ellio
tt
8.35
am -
8.
40am
Wel
com
e to
Co
untr
y
Aun
ty G
eorg
ina
Willi
ams,
Kau
rna
Peop
le
8.40
am -
8.
45am
C
om
mit
tee
Wel
com
e
Dr S
amue
l Ellio
tt, P
rinci
pal G
ener
al P
ract
ition
er, R
iver
side
Fam
ily M
edic
al P
ract
ice,
SA
, Aus
tral
ia
8.45
am -
8.
50am
Gov
ernm
ent W
elco
me
The
Hon
orab
le S
teph
en W
ade,
Min
iste
r for
Hea
lth a
nd W
ellb
eing
, SA
, Aus
tral
ia
8.50
am -
9.
10am
N
o o
ne le
ft b
ehin
d? T
he ro
le o
f so
cial
po
licy
in v
iral h
epat
itis
kylie
val
entin
e, D
eput
y D
irect
or, S
ocia
l Pol
icy
Rese
arch
Cen
tre,
UN
SW A
rt &
Soc
ial S
cien
ces,
UN
SW S
ydne
y, N
SW, A
ustr
alia
9.10
am -
9.
20am
H
ealt
h Eq
uity
= D
oin
g M
ore
for o
ur C
om
mun
ity
Kath
ryn
Leaf
e, E
xecu
tive
Dire
ctor
, New
Zea
land
Nee
dle
Exch
ange
Pro
gram
me
(NES
T),
Chr
istc
hurc
h, N
ew Z
eala
nd
9.20
am -
9.
30am
Li
ved
expe
rien
ce s
peak
er, A
bori
gina
l and
To
rres
Str
ait I
slan
der H
ealt
h
Ann
e M
itche
ll
9.30
am -
10
.00a
m
Elim
inat
ion
of H
epat
itis
C in
Peo
ple
Who
Inje
ct D
rugs
in L
ow a
nd M
iddl
e In
com
e C
oun
trie
s: T
he F
inal
Fro
ntie
r
Dr S
unil S
olom
on, A
ssoc
iate
Pro
fess
or o
f Med
icin
e, J
ohn
Hop
kins
Uni
vers
ity S
choo
l of M
edic
ine,
USA
1 2
MO
ND
AY,
13
AU
GU
ST
20
18
10.0
0am
-
10.3
0am
T
he P
oten
tial
Impa
ct o
f a C
ure
for C
hro
nic
Hep
atit
is B
Infe
ctio
n: A
Po
pula
tio
n H
ealt
h an
d Ec
ono
mic
Ana
lysi
s in
Aus
tral
ia
Dr M
ehlik
a To
y, R
esea
rch
Scie
ntis
t, St
anfo
rd U
nive
rsity
, USA
10.3
0am
-
10.4
0am
A
ustr
alia
n H
epat
itis
Elim
inat
ion
Sco
reca
rd: P
rogr
ess
sinc
e th
e A
ustr
alas
ian
Vira
l Hep
atit
is E
limin
atio
n C
onf
eren
ce
Dr J
osep
h D
oyle
, Sen
ior L
ectu
rer,
Mon
ash
Uni
vers
ity a
nd A
lfred
Hea
lth; D
eput
y D
irect
or, D
isea
se E
limin
atio
n Pr
ogra
m, B
urne
t Ins
titut
e,
Mel
bour
ne, V
IC, A
ustr
alia
10.4
0am
-
10.5
0am
N
atio
nal S
trat
egie
s A
ustr
alia
A re
pres
enta
tive
from
the
Com
mon
wea
lth D
epar
tmen
t of H
ealth
10.5
0am
-
11.0
0am
New
Zea
land
s Pa
thw
ay to
Elim
inat
ion
Dr A
lex
Lam
pen-
Smith
, Gas
troe
nter
olog
ist a
nd C
linic
al D
irect
or, H
epat
itis
Foun
datio
n of
New
Zea
land
11.0
0am
-
11.4
5am
M
orn
ing
Tea
and
Po
ster
Vie
win
g
Room
: Exh
ibiti
on H
all L
11.4
5am
-
1.15
pmC
ross
Tra
ck S
ympo
sium
1 -
Co
mm
unit
y En
gage
men
t
Room
: Hal
l M | C
hairs
: Mar
gare
t Hel
lard
and
Ena
am O
udih
11.4
5am
-
11.5
7am
D
eadl
y Li
ver M
ob:
Est
ablis
hing
New
Ser
vice
s to
Eng
age
Abo
rigi
nal P
eopl
e w
ho in
ject
in H
epat
itis
C a
nd S
TI S
cree
ning
(#13
0)
Mel
inda
Wal
ker,
Rese
arch
Offi
cer,
Cen
tre
for S
ocia
l Res
earc
h in
Hea
lth, U
NSW
Syd
ney
and
Kerr
ie-A
nne
Smith
, Wes
tern
Syd
ney
Loca
l H
ealth
Dis
tric
t, N
SW, A
ustr
alia
11.5
7am
-
12.0
9pm
Bey
ond
Info
rmat
ion
- H
epat
itis
B E
ngag
emen
t wit
h th
e C
hine
se C
om
mun
ity
in A
dela
ide
(#35
)
Cec
ilia L
im, C
oord
inat
or In
form
atio
n Re
sour
ces,
Hep
atiti
s SA
, SA
, Aus
tral
ia a
nd M
arge
ry M
ilner
, Vira
l Hep
atiti
s N
urse
, The
Que
en
Eliz
abet
h H
ospi
tal, A
dela
ide,
SA
, Aus
tral
ia
1 3
MO
ND
AY,
13
AU
GU
ST
20
18
12.0
9pm
-
12.2
1pm
Too
so
on
for b
ack-
slap
ping
and
co
unti
ng c
hick
ens:
Eng
agem
ent w
ith
sub-
popu
lati
ons
of p
eopl
e w
ho u
se d
rugs
Mel
anie
Wal
ker,
Chi
ef E
xecu
tive
Offi
cer,
Aus
tral
ian
Inje
ctin
g &
Illic
it D
rug
Use
rs L
eagu
e (A
IVL)
, Can
berr
a, A
CT,
Aus
tral
ia
12.2
1pm
-
12.3
3pm
B
arri
ers
and
Faci
litat
ors
for E
nsur
ing
Equi
tabl
e A
cces
s to
DA
As:
A C
linic
al P
ersp
ecti
ve
Dr P
hilip
Rea
d, D
irect
or, K
irket
on R
oad
Cen
tre,
NSW
, Aus
tral
ia
12.3
3pm
-
12.4
5pm
C
olla
bora
tive
Par
tner
ship
s ar
e N
eede
d to
Elim
inat
e H
epat
itis
C in
Mar
gina
lised
Po
pula
tio
ns
Jani
ce P
ritch
ard-
Jone
s, H
epat
itis
Coo
rdin
ator
, Syd
ney
Loca
l Hea
lth D
istr
ict,
Sydn
ey, N
SW, A
ustr
alia
12.4
5pm
-
12.5
5pm
Q
&A
12.5
5pm
-
1.15
pm
Pane
l Dis
cuss
ion
Faci
litat
ors:
Mar
gare
t Hel
lard
, Ena
am O
udih
. Pan
ellis
ts: C
hen
Bin,
Syl
Phi
llips-
Ayre
, Cat
herin
e Ko
stov
ski,
Sion
e C
raw
ford
, Jud
e By
rne,
Ja
ck W
alla
ce a
nd D
ebor
ah W
arne
ke-A
rnol
d
1.15
pm -
2.
15pm
Lunc
h an
d Po
ster
Vie
win
g
Room
: Exh
ibiti
on H
all L
1.15
pm -
2.
15pm
Earl
y C
aree
r Net
wo
rkin
g Ev
ent
Room
: L3
| Sun
il Sol
omon
, Mar
gare
t Hel
lard
, And
rew
Llo
yd, M
icha
el N
inbu
rg, a
nd K
athe
rine
McQ
uilla
n
1.35
pm -
2.
05pm
Po
ster
To
ur -
Co
mm
unit
y &
So
cial
Res
earc
h T
hem
e.
Room
: Exh
ibiti
on H
all |
Faci
litat
or: k
ylie
val
entin
e
1.35
pm -
1.
40pm
#2
– Lo
ok
Aft
er Y
our
Blo
od
– D
evel
opi
ng a
Blo
od-
Bo
rne
Vir
us S
oci
al M
arke
ting
Cam
paig
n fo
r Yo
ung
Abo
rigi
nal P
eopl
e (#
71
Judi
th B
evan
1 4
MO
ND
AY,
13
AU
GU
ST
20
18
1.40
pm -
1.
45pm
#3
– R
eori
enta
tio
n o
f Hep
atit
is C
Ser
vice
s in
Vic
tori
a (#
51)
Eliz
abet
h Bi
rbilis
1.45
pm -
1.
50pm
#5
– C
om
mun
ity
Co
nver
sati
ons
wit
h Pe
ole
Who
Inje
ct D
rugs
in S
out
hern
Syd
ney
(#62
)
Trac
ey B
row
n
1.50
pm -
1.
55pm
#6
– Pe
er In
sigh
ts: U
nder
stan
ding
Mot
ivat
ors
and
Bar
rier
s to
the
Upt
ake
of H
epat
itis
C T
reat
men
ts a
mo
ng P
eopl
e W
ho In
ject
D
rugs
(#21
) Su
san
Cho
ng
1.55
pm -
2.
00pm
#14
– B
arri
ers
and
Hel
p-S
eeki
ng P
ract
ices
: Per
spec
tive
s o
f So
uth
Suda
nese
Peo
ple
wit
h C
hro
nic
Hep
atit
is B
in A
ustr
alia
(#
123)
Willi
am M
ude
2.00
pm -
2.
05pm
#15
– G
UD
WU
N P
OR
PLE
S |
Co
mm
unit
ies
Cre
atin
g fo
r Co
mm
unit
y: A
Sus
tain
able
Res
our
ce P
roje
ct (#
330)
Sam
anth
a W
hite
2.15
pm -
3.
45pm
Plen
ary
2 -
Plen
ary
pro
ffer
ed p
aper
abs
trac
t ses
sio
n
Room
: Hal
l M | C
hairs
: Sco
tt B
owde
n an
d Va
ness
a To
wel
l
2.15
pm -
2.
30pm
B
ig M
ob,
Big
Jo
b -
Hep
atit
is B
Ser
o-C
odi
ng T
he T
op
End
(#11
8)
Kelly
Hos
king
, Con
tinuo
us Q
ualit
y Im
prov
emen
t Fac
ilitat
or, T
op E
nd H
ealth
Ser
vice
, Nor
ther
n Te
rrito
ry G
over
nmen
t, N
T, A
ustr
alia
2.30
pm -
2.
45pm
H
epat
itis
B C
om
mun
ity
Part
ners
hips
- D
anci
ng w
ith
Cin
dere
lla (#
70)
Kath
ryn
Stew
art,
Prog
ram
Man
ager
- H
epat
itis
B, H
epat
itis
Aus
tral
ia, A
CT,
Aus
tral
ia
2.45
pm -
3.
00pm
Eval
uati
on
of T
he X
pert
® H
CV
Fin
gers
tick
Vira
l Lo
ad P
oin
t-o
f-C
are-
Ass
ay (#
65)
Dr T
anya
App
lega
te, S
enio
r Lec
ture
r, T
he K
irby
Inst
itute
, UN
SW S
ydne
y, N
SW, A
ustr
alia
1 5
MO
ND
AY,
13
AU
GU
ST
20
18
3.00
pm -
3.
15pm
H
epat
itis
C V
irus
Infe
ctio
n am
ong
Peo
ple
Who
Inje
ct D
rugs
In A
ustr
alia
: Mo
nito
ring
Exp
osu
re, T
reat
men
t Upt
ake
and
Vira
emic
Pre
vale
nce
(#98
)
Dr J
enny
Iver
sen,
Sen
ior L
ectu
rer,
The
Kirb
y In
stitu
te, U
NSW
Syd
ney,
NSW
, Aus
tral
ia
3.15
pm -
3.
30pm
Adh
eren
ce to
So
fosb
uvir
and
Vel
pata
svir
am
ong
Peo
ple
Wit
h C
hro
nic
HC
V In
fect
ion
and
Rec
ent I
njec
tio
n D
rug
Use
: The
S
impl
ify S
tudy
(#83
)
Evan
Cun
ning
ham
, Pos
tdoc
tora
l Fel
low
, The
Kirb
y In
stitu
te, U
NSW
Syd
ney,
NSW
, Aus
tral
ia
3.30
pm -
3.
45pm
The
Mat
ter o
f Rei
nfec
tio
n: A
ttit
udes
am
ong
Aus
tral
ian
Pris
one
rs fr
om
the
STo
P-C
Stu
dy (#
37)
Jake
Ran
ce, R
esea
rch
Fello
w, C
entr
e fo
r Soc
ial R
esea
rch
in H
ealth
, UN
SW S
ydne
y, N
SW, A
ustr
alia
3.45
pm -
4.
15pm
Aft
erno
on
Tea
and
Po
ster
Vie
win
g
Room
: Exh
ibiti
on H
all L
4.15
pm -
5.
45pm
Sym
posi
um -
Mea
suri
ng
Pro
gres
s To
war
ds V
iral H
epat
itis
El
imin
atio
n G
oal
s -
Dat
a fo
r A
ctio
n
Room
: Hal
l M | C
hairs
: Mar
k St
oove
an
d R
icha
rd G
ray
4.15
pm -
5.
45pm
Pro
ffer
ed P
aper
s -
Inno
vati
ons
in
Hep
atit
is B
Room
: City
Roo
m 1
| Cha
irs: J
ack
Wal
lace
and
Sus
an H
ay
4.15
pm -
5.
50pm
Pro
ffer
ed P
aper
s -
Tes
ting
, Tr
eati
ng a
nd C
ance
r Scr
eeni
ng
Room
: City
Roo
m 2
| Cha
irs: S
cott
Bo
wde
n an
d M
arge
ry M
ilner
4.15
pm -
4.
30pm
Stra
tegi
es, T
arge
ts a
nd
Indi
cato
rs.
How
Will
We
Mea
sure
our
Pro
gres
s To
war
ds
Hep
atit
is B
and
Hep
atit
is C
El
imin
atio
n
Prof
esso
r Mar
gare
t Hel
lard
, D
eput
y D
irect
or, B
urne
t Ins
titut
e,
VIC
, Aus
tral
ia
4.15
pm -
4.
30pm
No
Dra
mas
: Elim
inat
ing
Hep
atit
is B
- R
elat
ed S
ham
e In
The
Chi
nese
Co
mm
unit
y (#
326
)
Win
Yee
Tan
4.15
pm -
4.
30pm
Man
agem
ent o
f Vira
l Hep
atit
is
in L
ower
Mid
dle
Inco
me
Co
untr
ies
- M
akin
g th
e be
st o
f w
hat w
e ha
ve
Dr S
unil S
olom
on, A
ssoc
iate
Pr
ofes
sor o
f Med
icin
e, J
ohn
Hop
kins
Uni
vers
ity S
choo
l of
Med
icin
e, U
SA
1 6
MO
ND
AY,
13
AU
GU
ST
20
18
4.30
pm -
4.
45pm
H
BV a
nd H
CV
Elim
inat
ion
Targ
ets:
Whi
ch a
re fe
asib
le?
Prof
esso
r Gre
gory
Dor
e, H
ead
Vira
l Hep
atiti
s C
linic
al R
esea
rch
Prog
ram
, The
Kirb
y In
stitu
te,
UN
SW S
ydne
y, N
SW, A
ustr
alia
4.30
pm -
4.
45pm
Peer
Sup
port
Ser
vice
for
Cul
tura
lly a
nd L
ingu
isti
cally
D
iver
se (C
ALD
) Peo
ple
Livi
ng
Wit
h H
epat
itis
B -
The
Eff
ort
s,
The
Ris
ks a
nd th
e B
enefi
ts (#
80)
Enaa
m O
udih
4.30
pm -
4.
45pm
Aus
tral
ian
cons
ensu
s st
atem
ent
on
hepa
titi
s B
man
agem
ent
duri
ng im
mun
osu
ppre
ssio
n fo
r ha
emat
olo
gica
l and
so
lid-o
rgan
m
alig
nanc
ies
(#33
2)
Jose
ph D
oyle
4.45
pm -
5.
00pm
The
Ro
le o
f Geo
-map
ping
of
Vira
l Hep
atit
is in
Mo
nito
ring
C
are
Cas
cade
and
Dri
ving
Lo
cal
Res
pons
es
Benj
amin
Cow
ie, E
pide
mio
logi
st,
The
Doh
erty
Inst
itute
, VIC
, A
ustr
alia
4.45
pm -
5.
00pm
Ove
rco
min
g La
ngua
ge a
nd
Cul
tura
l Bar
rier
s –
Enga
ging
N
on-
Engl
ish
Spea
king
C
om
mun
itie
s fo
r Edu
cati
on
(#10
2)
Zhi
hong
Gu
4.45
pm -
5.
00pm
Pred
icti
ng R
isk
of H
epat
oce
llula
r C
arci
nom
a fo
r Pat
ient
s w
ith
Chr
oni
c H
epat
itis
B U
sing
S
erum
Lev
els
of S
plic
ed
Hep
atit
is B
Vir
us D
NA
(#49
)
Pete
r Rev
ill
5.00
pm -
5.
15pm
Po
pula
tio
n-le
vel i
mpa
ct o
f DA
A
trea
tmen
t pro
gram
s
Mar
yam
Ala
vi, L
ectu
rer,
The
Kirb
y In
stitu
te, U
NSW
Syd
ney,
NSW
, A
ustr
alia
5.00
pm -
5.
15pm
HEP
B 1
, 2, 3
: Hep
atit
is B
C
om
mun
ity
Mo
bilis
atio
n an
d Im
mun
isat
ion
(#26
)
Meg
Per
rier
5.00
pm -
5.
15pm
Inve
stig
atin
g th
e U
se o
f a
Uri
nary
Met
abo
lite
Pane
l as
a S
cree
ning
Tes
t fo
r Dia
gno
sis
of H
epat
oce
llula
r Car
cino
ma
in a
Rem
ote
Abo
rigi
nal S
etti
ng
(#12
5)
Jack
Wan
g an
d Ke
vin
Mul
ler
5.15
pm -
5.
45pm
Faci
litat
or: M
ark
Stoo
ve
Pane
l: R
icha
rd G
ray,
Mar
gare
t H
ella
rd, G
reg
Dor
e, B
enja
min
C
owie
, Mar
yam
Ala
vi, T
im D
uck
and
Philli
p Re
ad
5.15
pm -
5.
30pm
Hip
Ho
p A
s A
Nar
rati
ve T
oo
l fo
r H
epat
itis
B a
nd L
iver
Can
cer
Prev
enti
on
(#74
)
Nafi
sa Y
ussf
5.15
pm -
5.
30pm
Synt
hesi
s o
f Hbe
ag-S
peci
fic
Epit
ope
-Clo
ned
HBV
Bio
-N
ano
part
icle
s (#
48)
Yian
ni D
roun
gas
1 7
MO
ND
AY,
13
AU
GU
ST
20
18
5.30
pm -
5.
35pm
Do
Bro
ad P
opu
lati
on
Hea
lth
Pro
mot
ion
Cam
paig
ns R
each
C
ALD
Co
mm
unit
ies?
(#34
)
Nat
ali S
mud
5.30
pm -
5.
35pm
Ev
alua
tio
n O
f A H
epat
itis
C
Vir
us C
ore
Ant
igen
Ass
ay In
D
ried
-Blo
od
Spot
s: A
Co
hort
St
udy
(#75
)
Tany
a A
pple
gate
5.35
pm -
5.
40pm
“Wat
ch, T
alk,
Sha
re”
- A
C
om
mun
ity
App
roac
h in
D
evel
opi
ng V
iral H
epat
itis
Vid
eo
for t
he V
ietn
ames
e C
om
mun
ity
(#10
4)
Zhi
hong
Gu
and
Trie
t Min
h H
o (S
teve
n)
5.35
pm -
5.
40pm
Cap
acit
y o
f No
n-In
vasi
ve
Hep
atic
Fib
rosi
s A
lgo
rith
ms
to
Rep
lace
Tra
nsie
nt E
last
ogr
aphy
to
Exc
lude
Cir
rho
sis
in P
eopl
e w
ith
Hep
atit
is C
Vir
us In
fect
ion:
A
Mul
ti-C
entr
e O
bser
vati
ona
l St
udy
(#3)
Mel
issa
Kel
ly
5.40
pm -
5.
45pm
Q&
A5.
40pm
-
5.45
pmEv
alua
tio
n o
f the
Ho
logi
c A
ptim
a H
CV
Qua
nt D
iagn
ost
ic
Ass
ay fo
r Det
ecti
on
of H
CV
R
NA
fro
m D
ried
Blo
od
Spot
s (#
63)
Beth
Cat
lett
5.45
pm -
5.
50pm
An
Imm
uno
chro
mat
ogr
aphi
c T
est f
or M
easu
rem
ent o
f A
lani
ne A
min
otra
nsfe
rase
(ALT
) at
Po
int-
of-
Car
e (#
91)
Dav
id A
nder
son
5.45
pm -
7.
00pm
Wel
com
e R
ecep
tio
n an
d Po
ster
Vie
win
g, in
clud
ing
CS
RH
and
ND
RI:
Hea
lth
Pro
mot
ion
Priz
e A
nno
unce
men
t
Room
: Exh
ibiti
on H
all
1 8
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
7.00
amR
egis
trat
ion
ope
ns
8.45
am -
11
.00a
mPl
enar
y 3
Room
: Hal
l M | C
hairs
: Van
essa
Tow
ell a
nd H
elen
Tyr
rell
8.45
am -
9.
00am
H
epat
itis
C L
ived
exp
erie
nce
spea
ker
Solo
mon
Wor
eta
9.00
am -
9.
05am
"B
-Sid
e” P
roje
ct-
Incr
easi
ng A
war
enes
s o
f Hep
atit
is B
By
Mus
ic, M
ulti
med
ia S
tory
Bo
ard
and
So
cial
Med
ia C
ampa
ign
(#13
7)
Sure
sh S
harm
a, N
urse
Pra
ctiti
oner
, Joh
n H
unte
r Hos
pita
l - D
epar
tmen
t of G
astr
oent
erol
ogy,
New
cast
le, N
SW, A
ustr
alia
9.05
am -
9.
15am
A
nnua
l Rep
ort
on
the
Hep
atit
is C
asca
des
of C
are,
Tre
nds
and
Beh
avio
ur -
The
Kir
by In
stit
ute,
UN
SW
Syd
ney
and
Cen
tre
for
So
cial
Res
earc
h in
Hea
lth,
UN
SW
Syd
ney
Gre
g D
ore
and
Car
la T
relo
ar
9.15
am -
9.
45am
M
anag
emen
t of C
hro
nic
Hep
atit
is B
: Cha
lleng
ing
The
rape
utic
Par
adig
ms?
Ass
ocia
te P
rofe
ssor
Gai
l Mat
thew
s, V
iral H
epat
itis
Clin
ical
Res
earc
h Pr
ogra
m, T
he K
irby
Inst
itute
, UN
SW S
ydne
y, N
SW, A
ustr
alia
9.45
am -
10
.15a
m
Vira
l Hep
atit
is, H
arm
Red
ucti
on
and
Who
le P
erso
n H
ealt
h: th
e Ro
le o
f Co
mm
unit
y-ba
sed
Org
aniz
atio
ns
Mic
hael
Nin
burg
, Pre
side
nt, T
he W
orld
Hep
atiti
s A
llianc
e; E
xecu
tive
Dire
ctor
, The
Hep
atiti
s Ed
ucat
ion
Proj
ect,
USA
10.1
5am
-
10.4
5am
Le
sso
ns fr
om
the
insi
de: E
nhan
cing
hep
atit
is B
and
C p
reve
ntio
n an
d tr
eatm
ent i
n th
e pr
iso
n se
cto
r
Prof
esso
r And
rew
Llo
yd, I
nfec
tious
Dis
ease
s Ph
ysic
ian
and
Imm
unov
iorlo
gy R
esea
rche
r, T
he K
irby
Inst
itute
, UN
SW S
ydne
y, N
SW,
Aus
tral
ia
10.4
5am
-
11.0
0am
The
Lev
inia
Cro
oks
Em
ergi
ng L
eade
r Aw
ard
Pres
enta
tio
n: M
easu
ring
dis
pari
ties
in p
rogr
ess
tow
ard
elim
inat
ion:
Usi
ng d
ata
for a
ctio
n
Aw
ard
awar
d pr
esen
ted
by V
anes
sa T
owel
l, Nat
iona
l Pol
icy
and
Educ
atio
n D
ivis
ion
Man
ager
, The
Aus
tral
asia
n So
ciet
y fo
r HIV
, Vira
l H
epat
itis
and
Sexu
al H
ealth
Med
icin
e, N
SW, A
ustr
alia
.
1 9
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
7.00
amR
egis
trat
ion
ope
ns
8.45
am -
11
.00a
mPl
enar
y 3
Room
: Hal
l M | C
hairs
: Van
essa
Tow
ell a
nd H
elen
Tyr
rell
8.45
am -
9.
00am
H
epat
itis
C L
ived
exp
erie
nce
spea
ker
Solo
mon
Wor
eta
9.00
am -
9.
05am
"B
-Sid
e” P
roje
ct-
Incr
easi
ng A
war
enes
s o
f Hep
atit
is B
By
Mus
ic, M
ulti
med
ia S
tory
Bo
ard
and
So
cial
Med
ia C
ampa
ign
(#13
7)
Sure
sh S
harm
a, N
urse
Pra
ctiti
oner
, Joh
n H
unte
r Hos
pita
l - D
epar
tmen
t of G
astr
oent
erol
ogy,
New
cast
le, N
SW, A
ustr
alia
9.05
am -
9.
15am
A
nnua
l Rep
ort
on
the
Hep
atit
is C
asca
des
of C
are,
Tre
nds
and
Beh
avio
ur -
The
Kir
by In
stit
ute,
UN
SW
Syd
ney
and
Cen
tre
for
So
cial
Res
earc
h in
Hea
lth,
UN
SW
Syd
ney
Gre
g D
ore
and
Car
la T
relo
ar
9.15
am -
9.
45am
M
anag
emen
t of C
hro
nic
Hep
atit
is B
: Cha
lleng
ing
The
rape
utic
Par
adig
ms?
Ass
ocia
te P
rofe
ssor
Gai
l Mat
thew
s, V
iral H
epat
itis
Clin
ical
Res
earc
h Pr
ogra
m, T
he K
irby
Inst
itute
, UN
SW S
ydne
y, N
SW, A
ustr
alia
9.45
am -
10
.15a
m
Vira
l Hep
atit
is, H
arm
Red
ucti
on
and
Who
le P
erso
n H
ealt
h: th
e Ro
le o
f Co
mm
unit
y-ba
sed
Org
aniz
atio
ns
Mic
hael
Nin
burg
, Pre
side
nt, T
he W
orld
Hep
atiti
s A
llianc
e; E
xecu
tive
Dire
ctor
, The
Hep
atiti
s Ed
ucat
ion
Proj
ect,
USA
10.1
5am
-
10.4
5am
Le
sso
ns fr
om
the
insi
de: E
nhan
cing
hep
atit
is B
and
C p
reve
ntio
n an
d tr
eatm
ent i
n th
e pr
iso
n se
cto
r
Prof
esso
r And
rew
Llo
yd, I
nfec
tious
Dis
ease
s Ph
ysic
ian
and
Imm
unov
iorlo
gy R
esea
rche
r, T
he K
irby
Inst
itute
, UN
SW S
ydne
y, N
SW,
Aus
tral
ia
10.4
5am
-
11.0
0am
The
Lev
inia
Cro
oks
Em
ergi
ng L
eade
r Aw
ard
Pres
enta
tio
n: M
easu
ring
dis
pari
ties
in p
rogr
ess
tow
ard
elim
inat
ion:
Usi
ng d
ata
for a
ctio
n
Aw
ard
awar
d pr
esen
ted
by V
anes
sa T
owel
l, Nat
iona
l Pol
icy
and
Educ
atio
n D
ivis
ion
Man
ager
, The
Aus
tral
asia
n So
ciet
y fo
r HIV
, Vira
l H
epat
itis
and
Sexu
al H
ealth
Med
icin
e, N
SW, A
ustr
alia
.
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
11.0
0am
-
11.3
0am
Mo
rnin
g T
ea a
nd P
ost
er V
iew
ing
Room
: Exh
ibiti
on H
all L
11.3
0am
-
1.00
pmC
ross
Tra
ck S
ympo
sium
2 -
Vira
l Hep
atit
is in
Co
rrec
tio
nal S
etti
ngs
Room
: Hal
l M | C
hairs
: And
rew
Llo
yd a
nd M
ark
Stoo
ve
11.3
0am
-
11.4
0am
T
he ro
le o
f Co
rrec
tive
Ser
vice
s an
d Ju
stic
e H
ealt
h st
aff in
Pro
mot
ing
HC
V T
reat
men
t Upt
ake
amo
ng th
e Pr
iso
ner P
opu
lati
on
in N
SW
Co
rrec
tio
nal C
entr
es
Prof
esso
r Car
la T
relo
ar, D
irect
or, C
entr
e fo
r Soc
ial R
esea
rch
in H
ealth
, UN
SW S
ydne
y, N
SW, A
ustr
alia
11.4
0am
-
11.5
0am
Hea
lthE
Link
, Onl
ine
Mo
del o
f HC
V T
reat
men
t wit
hin
So
uth
Aus
tral
ian
Pris
ons
Dr E
dmun
d Ts
e, H
ead
of H
epat
olog
y an
d St
aff S
peci
alis
t, Ro
yal A
dela
ide
Hos
pita
l, SA
, Aus
tral
ia
11.5
0am
-
12.0
0pm
HC
V T
rans
mis
sio
n an
d R
isk
Beh
avio
ur in
NS
W P
riso
ns
Dr B
ehza
d H
ajar
i, Le
ctur
er, T
he K
irby
Inst
itute
, UN
SW S
ydne
y, N
SW, A
ustr
alia
12.0
0pm
-
12.1
0pm
Nur
se-l
ed m
ode
l of H
CV
car
e an
d tr
eatm
ent i
n V
IC p
riso
ns
Ann
e C
raig
ie, H
epat
itis
Clin
ical
Nur
se C
onsu
ltant
, St V
ince
nt's
Hos
pita
l Mel
bour
ne, V
IC, A
ustr
alia
12.1
0pm
-
12.2
0pm
H
BV P
reva
lenc
e, P
reve
ntio
n an
d Tr
eatm
ent i
n N
T P
riso
ns
Dr J
ane
Dav
ies,
Infe
ctio
us D
isea
ses
Spec
ialis
t, M
enzi
es S
choo
l of H
ealth
Res
earc
h, N
T, A
ustr
alia
12.2
0pm
-
13.0
0pm
Faci
litat
or: A
ndre
w L
loyd
. Pan
ellis
t: M
ark
Stoo
ve, C
arla
Tre
loar
, Edm
und
Tse,
Beh
zad
Haj
ari,
Jane
Dav
ies,
Ann
e C
raig
ie,M
icha
el N
inbu
rg,
Shan
non
Wrig
ht a
nd M
icha
el L
evy
1.00
pm -
2.
00pm
Lunc
h an
d Po
ster
Vie
win
g
Room
: Exh
ibiti
on H
all L
2 0
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
1.00
pm -
2.
00pm
Mo
delli
ng W
ork
sho
p
Room
: L3
1.05
pm -
1.
20pm
Intr
odu
ctio
n -
Wha
t are
mo
dels
and
wha
t pur
pose
do
they
ser
ve?
Dr K
aren
McC
ullo
ch, R
esea
rch
Fello
w, T
he D
oher
ty In
stitu
te, M
elbo
urne
, VIC
, Aus
tral
ia
1.20
pm -
1.
30pm
Mo
delli
ng fo
r Hep
atit
is C
Dr N
ick
Scot
t, Ec
onom
etric
ian,
Bur
net I
nstit
ute,
VIC
, Aus
tral
ia
1.30
pm -
1.
40pm
Mo
delli
ng fo
r Hep
atit
is B
Dr K
aren
McC
ullo
ch, R
esea
rch
Fello
w, T
he D
oher
ty In
stitu
te, M
elbo
urne
, VIC
, Aus
tral
ia
1.40
pm -
2.
00pm
Q&
A D
iscu
ssio
n w
ith
Pane
l
Meh
lika
Toy,
Nic
k Sc
ott,
Kare
n M
cCul
loch
and
Ric
hard
Gra
y
1.20
pm -
1.
50pm
Post
er T
our
- P
ublic
Hea
lth
and
Clin
ical
Car
e
Room
: Exh
ibiti
on H
all |
Faci
litat
or: A
lisa
Pedr
ana.
1.20
pm -
1.
25pm
#36
– E
pide
mio
logi
c Tr
ends
in V
iral H
epat
itis
Not
ifica
tio
ns in
Aus
tral
ia, 1
996-
2016
(#14
0)
Laur
a T
hom
as
1.25
pm -
1.
30pm
#37
– H
epat
itis
B S
tatu
s Is
Sig
nific
antl
y A
sso
ciat
ed W
ith
Sex
ually
Tra
nsm
issi
ble
Infe
ctio
n Po
siti
vity
– A
Cas
e C
ont
rolle
d St
udy
At A
Pub
licly
Fun
ded
Sex
ual H
ealt
h S
ervi
ce In
Syd
ney,
Aus
tral
ia (#
143)
Ric
k Va
rma
2 1
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
1.30
pm -
1.
35pm
#44
– O
utco
mes
Of C
om
mun
ity-
Bas
ed H
epat
itis
C T
reat
men
t Usi
ng A
n Eh
ealt
h M
ode
l Of C
are
(#58
)
Jam
es H
arid
y
1.35
pm -
1.
40pm
#45
– N
urse
s Ro
le w
hen
the
Hep
atit
is C
is C
ured
But
the
Cir
rho
sis
Rem
ains
(#32
9)
Jani
ce P
ritch
ard-
Jone
s
2.00
pm -
3.
30pm
Sym
posi
um -
Sim
plify
ing
diag
nosi
s an
d tr
eatm
ent f
or
hepa
titi
s B
& C
– n
ow a
nd in
to
the
futu
re
Room
: Hal
l M | C
hairs
: Gai
l M
atth
ews
and
Mel
anie
Eag
le
2.00
pm -
3.
30pm
Pro
ffer
ed P
aper
s -
Res
pond
ing
to C
halle
nges
in H
epat
itis
C
Car
e an
d Tr
eatm
ent
Room
: City
Roo
m 1
| Cha
irs: k
ylie
va
lent
ine
and
Tom
Ree
s
2.00
pm -
3.
30pm
Pro
ffer
ed P
aper
s -
Hep
atit
is
Trea
tmen
t an
d It
s Im
pact
Room
: City
Roo
m 2
| Cha
irs:
Sam
uel E
lliott
and
Alis
a Pe
dran
a
2.00
pm -
2.
15pm
S
impl
ifica
tio
n an
d Im
plem
enta
tio
n o
f Exi
stin
g D
iagn
osi
s To
ols
– H
ow C
an w
e U
se W
hat w
e H
ave?
Dr T
anya
App
lega
te, S
enio
r Le
ctur
er, T
he V
iral H
epat
itis
Clin
ical
Res
earc
h Pr
ogra
m, T
he
Kirb
y In
stitu
te, U
NSW
Syd
ney,
N
SW, A
ustr
alia
2.00
pm -
2.
15pm
H
ear Y
e! H
ear Y
e! G
etti
ng O
ut
The
Go
od
New
s o
n H
ep C
Cur
e (#
73)
Gra
ce C
row
ley
2.00
pm -
2.
15pm
O
ngo
ing
Bur
den
of A
dvan
ced
Live
r Dis
ease
Co
mpl
icat
ions
D
espi
te R
apid
HC
V T
reat
men
t S
cale
-Up
(#77
)
(Jis
oo) A
my
Kwon
2 2
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
2.15
pm -
2.
30pm
The
Dev
elo
pmen
t of N
ew
Sim
plifi
ed D
iagn
ost
ic
Tec
hno
logi
es to
Rea
ch th
ose
in
Nee
d –
Our
Cha
lleng
es fo
r the
N
ext 5
Yea
rs
Ass
ocia
te P
rofe
ssor
Dav
id
And
erso
n, D
eput
y D
irect
or, T
he
Burn
et In
stitu
te, M
elbo
urne
, VIC
, A
ustr
alia
2.15
pm -
2.
30pm
The
Nat
iona
l Sti
gma
Indi
cato
r Pr
oje
ct: K
ey F
indi
ngs
And
Le
sso
ns R
egar
ding
Peo
ple
Livi
ng W
ith
HC
V A
nd P
eopl
e W
ho In
ejct
Dru
gs (#
23)
Tim
othy
Bro
ady
2.15
pm -
2.
30pm
Map
ping
Pro
gres
s To
war
ds
Aus
tral
ia’s
Nat
iona
l Hep
atit
is C
St
rate
gy T
arge
ts (#
327)
Jenn
ifer M
acLa
chla
n
2.30
pm -
2.
45pm
C
linic
al C
halle
nges
for
the
Sim
plifi
cati
on
of H
CV
Tr
eatm
ent -
Opt
imis
ing
the
Car
e C
asca
de
Dr A
man
da W
ade,
ID P
hysi
cian
, H
ead
Hep
atiti
s C
linic
Gee
long
H
ospi
tal a
nd E
C W
est,
VIC
, A
ustr
alia
2.30
pm -
2.
45pm
R
easo
ns F
or N
ot S
eeki
ng H
CV
Tr
eatm
ent A
mo
ng A
Sam
ple
Of
Peo
ple
Who
Inje
ct D
rugs
(#60
)
Leith
Mor
ris
2.30
pm -
2.
45pm
Pr
ogr
ess
Tow
ards
Hep
atit
is
Elim
inat
ion
in M
ong
olia
: Ini
tial
O
utco
mes
of t
he H
ealt
hy L
iver
N
atio
nal P
rogr
am 2
017-
2020
(#
56)
Nar
antu
ya J
adam
baa
2.45
pm -
3.
00pm
Sim
plifi
cati
on
of H
BV
Trea
tmen
t to
Rea
ch E
very
one
-
Wha
t To
ols
do
we
Nee
d to
En
gage
Abo
rigi
nal &
To
rres
St
rait
Isla
nder
and
CA
LD
Co
mm
unit
ies?
Dr J
ane
Dav
ies,
Infe
ctio
us
Dis
ease
s Sp
ecia
list,
Men
zies
Sc
hool
of H
ealth
Res
earc
h, N
T,
Aus
tral
ia
2.45
pm -
3.
00pm
“I
Lov
e N
ot B
eing
Infe
cto
us…
”:
Perc
epti
ons
Of H
epat
itis
C C
ure
Post
DA
A T
reat
emen
t (#
6)
Jacq
ui R
ichm
ond
2.45
pm -
3.
00pm
R
ecur
rent
Vira
emia
Fo
llow
ing
Succ
essf
ul H
CV
DA
A T
hera
py
amo
ng P
eopl
e w
ith
Rec
ent
Inje
ctin
g D
rug
Use
: The
Sim
plify
an
d D
3fea
t Stu
dies
(#14
2)
Evan
Cun
ning
ham
2 3
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
2.15
pm -
2.
30pm
The
Dev
elo
pmen
t of N
ew
Sim
plifi
ed D
iagn
ost
ic
Tec
hno
logi
es to
Rea
ch th
ose
in
Nee
d –
Our
Cha
lleng
es fo
r the
N
ext 5
Yea
rs
Ass
ocia
te P
rofe
ssor
Dav
id
And
erso
n, D
eput
y D
irect
or, T
he
Burn
et In
stitu
te, M
elbo
urne
, VIC
, A
ustr
alia
2.15
pm -
2.
30pm
The
Nat
iona
l Sti
gma
Indi
cato
r Pr
oje
ct: K
ey F
indi
ngs
And
Le
sso
ns R
egar
ding
Peo
ple
Livi
ng W
ith
HC
V A
nd P
eopl
e W
ho In
ejct
Dru
gs (#
23)
Tim
othy
Bro
ady
2.15
pm -
2.
30pm
Map
ping
Pro
gres
s To
war
ds
Aus
tral
ia’s
Nat
iona
l Hep
atit
is C
St
rate
gy T
arge
ts (#
327)
Jenn
ifer M
acLa
chla
n
2.30
pm -
2.
45pm
C
linic
al C
halle
nges
for
the
Sim
plifi
cati
on
of H
CV
Tr
eatm
ent -
Opt
imis
ing
the
Car
e C
asca
de
Dr A
man
da W
ade,
ID P
hysi
cian
, H
ead
Hep
atiti
s C
linic
Gee
long
H
ospi
tal a
nd E
C W
est,
VIC
, A
ustr
alia
2.30
pm -
2.
45pm
R
easo
ns F
or N
ot S
eeki
ng H
CV
Tr
eatm
ent A
mo
ng A
Sam
ple
Of
Peo
ple
Who
Inje
ct D
rugs
(#60
)
Leith
Mor
ris
2.30
pm -
2.
45pm
Pr
ogr
ess
Tow
ards
Hep
atit
is
Elim
inat
ion
in M
ong
olia
: Ini
tial
O
utco
mes
of t
he H
ealt
hy L
iver
N
atio
nal P
rogr
am 2
017-
2020
(#
56)
Nar
antu
ya J
adam
baa
2.45
pm -
3.
00pm
Sim
plifi
cati
on
of H
BV
Trea
tmen
t to
Rea
ch E
very
one
-
Wha
t To
ols
do
we
Nee
d to
En
gage
Abo
rigi
nal &
To
rres
St
rait
Isla
nder
and
CA
LD
Co
mm
unit
ies?
Dr J
ane
Dav
ies,
Infe
ctio
us
Dis
ease
s Sp
ecia
list,
Men
zies
Sc
hool
of H
ealth
Res
earc
h, N
T,
Aus
tral
ia
2.45
pm -
3.
00pm
“I
Lov
e N
ot B
eing
Infe
cto
us…
”:
Perc
epti
ons
Of H
epat
itis
C C
ure
Post
DA
A T
reat
emen
t (#
6)
Jacq
ui R
ichm
ond
2.45
pm -
3.
00pm
R
ecur
rent
Vira
emia
Fo
llow
ing
Succ
essf
ul H
CV
DA
A T
hera
py
amo
ng P
eopl
e w
ith
Rec
ent
Inje
ctin
g D
rug
Use
: The
Sim
plify
an
d D
3fea
t Stu
dies
(#14
2)
Evan
Cun
ning
ham
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
3.00
pm -
3.
30pm
Pane
l Dis
cuss
ion
Faci
litat
or: G
ail M
atth
ews.
Pa
nellis
ts: M
elan
ie E
agle
, Tan
ya
App
lega
te, D
avid
And
erso
n,
Am
anda
Wad
e, J
ane
Dav
ies,
Si
nead
She
ils a
nd S
usan
Hay
3.00
pm -
3.
15pm
St
ayin
g H
one
st A
bout
HC
V
Trea
tmen
t Acc
ess
– B
arri
ers
to T
reat
men
t fro
m a
QuI
HN
Pe
rspe
ctiv
e (#
113)
Tega
n N
ucke
y
3.00
pm -
3.
05pm
A
cces
sing
Hep
atit
is C
Tr
eatm
ent I
n N
ew S
out
h W
ales
: W
here
are
Peo
ple
who
Inje
ct
Dru
gs B
eing
Tre
ated
? (#
114)
Loui
se G
edde
s
3.15
pm -
3.
20pm
The
Ko
mbi
Clin
ic –
It’s
The
End
o
f The
Ro
ad fo
r Hep
C! (
#24
)
Mat
thew
Youn
g
3.05
pm -
3.
20pm
Hig
h Effi
cacy
of D
irec
t-A
ctin
g A
ntiv
iral T
hera
pies
for H
epat
itis
C
Fo
llow
ing
Uni
vers
al A
cces
s in
A
ustr
alia
: The
REA
CH
-C C
oho
rt
(#13
4)
Jasm
ine
Yee
3.20
pm -
3.
25pm
Stig
ma
Sto
ries
: Spe
akin
g U
p To
St
op
The
Sile
nt K
iller
(#13
)
Jack
Gun
n
3.20
pm -
3.
25pm
U
nive
rsal
Acc
ess
to D
AA
T
hera
py P
aves
the
Way
for
HC
V C
ont
rol a
nd E
limin
atio
n am
ong
Peo
ple
Livi
ng w
ith
HIV
in
Aus
tral
ia (#
28)
Mar
iann
e M
artin
ello
3.25
pm -
3.
30pm
Q&
A3.
25pm
-
3.30
pmR
evie
win
g H
arm
Red
ucti
on
Stra
tegi
es in
NS
W P
riso
ns:
A
Co
llabo
rati
ve A
ppro
ach
to
Red
uce
Tran
smis
sio
n o
f Blo
od
Bo
rne
Vir
uses
and
Sex
ually
Tr
ansm
issi
ble
Infe
ctio
ns (#
86)
Tom
Wrig
ht
2 4
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
3.30
pm -
4.
00pm
A
fter
noo
n T
ea a
nd P
ost
er V
iew
ing
Room
: Exh
ibiti
on H
all L
4.00
pm-
5.30
pmSy
mpo
sium
- A
Co
mm
unit
y Le
ns o
n th
e V
iral H
epat
itis
C
asca
de o
f Car
e
Room
: Hal
l M | C
hairs
: Mic
hael
N
inbu
rg a
nd L
ynna
ire M
atth
ews
4.00
pm-
5.30
pmPr
off
ered
Pap
ers
- C
are
and
Trea
tmen
t am
ong
key
po
pula
tio
ns
Room
: City
Roo
m 1
| Cha
irs:
Edm
und
Tse
and
Suza
nne
Shep
pard
-Law
4.00
pm-
5.30
pmPr
off
ered
Pap
ers
- Pr
iori
tisi
ng
Hep
atit
is B
- E
pide
mio
logy
and
Pr
ogr
am N
eed
Room
: City
Roo
m 2
| Cha
irs: N
icol
e A
llard
and
Yvo
nne
Dra
zic
4.00
pm -
4.
05pm
A
n in
tro
duct
ion
to th
e ca
scad
e o
f car
e
Prof
esso
r Car
la T
relo
ar, D
irect
or,
Cen
tre
for S
ocia
l Res
earc
h in
H
ealth
, UN
SW S
ydne
y, N
SW,
Aus
tral
ia
4.00
pm -
4.
15pm
Hep
atit
is C
Vir
us (H
CV
) R
einf
ecti
on
and
Inje
ctin
g R
isk
Beh
avio
r fo
llow
ing
Elba
svir
(E
br)/
Gra
zopr
evir
(Gzr
) Tr
eatm
ent i
n Pa
rtic
ipan
ts o
n O
piat
e A
goni
st T
hera
py (O
AT):
Co
-Sta
r Par
t B (
#59
)
Gre
gory
Dor
e
4.00
pm -
4.
15pm
Inve
stig
atin
g Tr
ends
in
Hep
atit
is B
Epi
dem
iolo
gy w
ithi
n In
dige
nous
Po
pula
tio
ns in
the
No
rthe
rn T
erri
tory
(#12
4)
Ash
leig
h Q
ama
4.05
pm -
4.
20pm
Who
and
Wha
t is
mis
sing
fro
m
the
hepa
titi
s C
trea
tmen
t C
asca
de o
f Car
e?
Sion
e C
raw
ford
, Chi
ef E
xecu
tive
Offi
cer,
Har
m R
educ
tion
Vic
toria
, A
ustr
alia
4.15
pm -
4.
30pm
Dai
ly D
osi
ng o
f Dir
ect A
ctin
g A
ntiv
irals
(DA
As)
fro
m a
Pub
lic
Opi
oid
Sub
stit
utio
n Tr
eatm
ent
(OST
) Pro
gram
for M
argi
nalis
ed
Clie
nts
in K
ings
Cro
ss, S
ydne
y (#
44)
Philli
p Re
ad
4.15
pm -
4.
30pm
Mo
delli
ng H
epat
itis
B In
A
ustr
alia
: Im
prov
ed E
stim
ates
o
f the
Bur
den
of D
isea
se (#
122)
Kare
n M
cCul
loch
2 5
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
3.30
pm -
4.
00pm
A
fter
noo
n T
ea a
nd P
ost
er V
iew
ing
Room
: Exh
ibiti
on H
all L
4.00
pm-
5.30
pmSy
mpo
sium
- A
Co
mm
unit
y Le
ns o
n th
e V
iral H
epat
itis
C
asca
de o
f Car
e
Room
: Hal
l M | C
hairs
: Mic
hael
N
inbu
rg a
nd L
ynna
ire M
atth
ews
4.00
pm-
5.30
pmPr
off
ered
Pap
ers
- C
are
and
Trea
tmen
t am
ong
key
po
pula
tio
ns
Room
: City
Roo
m 1
| Cha
irs:
Edm
und
Tse
and
Suza
nne
Shep
pard
-Law
4.00
pm-
5.30
pmPr
off
ered
Pap
ers
- Pr
iori
tisi
ng
Hep
atit
is B
- E
pide
mio
logy
and
Pr
ogr
am N
eed
Room
: City
Roo
m 2
| Cha
irs: N
icol
e A
llard
and
Yvo
nne
Dra
zic
4.00
pm -
4.
05pm
A
n in
tro
duct
ion
to th
e ca
scad
e o
f car
e
Prof
esso
r Car
la T
relo
ar, D
irect
or,
Cen
tre
for S
ocia
l Res
earc
h in
H
ealth
, UN
SW S
ydne
y, N
SW,
Aus
tral
ia
4.00
pm -
4.
15pm
Hep
atit
is C
Vir
us (H
CV
) R
einf
ecti
on
and
Inje
ctin
g R
isk
Beh
avio
r fo
llow
ing
Elba
svir
(E
br)/
Gra
zopr
evir
(Gzr
) Tr
eatm
ent i
n Pa
rtic
ipan
ts o
n O
piat
e A
goni
st T
hera
py (O
AT):
Co
-Sta
r Par
t B (
#59
)
Gre
gory
Dor
e
4.00
pm -
4.
15pm
Inve
stig
atin
g Tr
ends
in
Hep
atit
is B
Epi
dem
iolo
gy w
ithi
n In
dige
nous
Po
pula
tio
ns in
the
No
rthe
rn T
erri
tory
(#12
4)
Ash
leig
h Q
ama
4.05
pm -
4.
20pm
Who
and
Wha
t is
mis
sing
fro
m
the
hepa
titi
s C
trea
tmen
t C
asca
de o
f Car
e?
Sion
e C
raw
ford
, Chi
ef E
xecu
tive
Offi
cer,
Har
m R
educ
tion
Vic
toria
, A
ustr
alia
4.15
pm -
4.
30pm
Dai
ly D
osi
ng o
f Dir
ect A
ctin
g A
ntiv
irals
(DA
As)
fro
m a
Pub
lic
Opi
oid
Sub
stit
utio
n Tr
eatm
ent
(OST
) Pro
gram
for M
argi
nalis
ed
Clie
nts
in K
ings
Cro
ss, S
ydne
y (#
44)
Philli
p Re
ad
4.15
pm -
4.
30pm
Mo
delli
ng H
epat
itis
B In
A
ustr
alia
: Im
prov
ed E
stim
ates
o
f the
Bur
den
of D
isea
se (#
122)
Kare
n M
cCul
loch
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
4.20
pm -
4.
35pm
H
epat
itis
B a
nd th
e ca
scad
e o
f ca
re: T
esti
ng v
s sc
reen
ing
vs
diag
nosi
s vs
chr
oni
c in
fect
ion
vs
infe
ctio
us v
s liv
er d
isea
se
Dr J
ack
Wal
lace
, Sen
ior R
esea
rch
Offi
cer,
Burn
et In
stitu
te, V
IC,
Aus
tral
ia a
nd N
afisa
Yus
sf,
Com
mun
ity E
ngag
emen
t Offi
cer,
Can
cer C
ounc
il Vic
toria
, Aus
tral
ia
4.30
pm -
4.
45pm
Prev
alen
ce o
f Ns5
a R
esis
tanc
e A
sso
ciat
ed S
ubst
itut
ions
and
H
CV
DA
A T
reat
men
t Out
com
es
amo
ng P
eopl
e Li
ving
Wit
h H
IV In
A
ustr
alia
(#12
7)
Tany
a A
pple
gate
4.30
pm -
4.
45pm
Hep
atit
is B
Tre
atm
ent i
n A
ustr
alia
– W
hat’
s T
he M
agic
N
umbe
r? (#
129)
Nic
ole
Rom
ero
4.35
pm -
4.
50pm
Usi
ng L
iver
Can
cer P
reve
ntio
n M
essa
ges
to S
cale
Up
Dia
gno
sis
of P
eopl
e w
ith
Hep
atit
is B
(#67
)
Emily
Ada
mso
n, P
olic
y an
d Pr
ogra
m A
dvis
or, C
ance
r Cou
ncil
Vic
toria
, Aus
tral
ia
4.45
pm -
5.
00pm
Phyl
oge
neti
c C
lust
erin
g Pa
tter
ns a
mo
ng P
eopl
e Li
ving
w
ith
HIV
and
Hep
atit
is C
in
Aus
tral
ia (#
128)
Tany
a A
pple
gate
4.45
pm -
5.
00pm
Mo
rbid
ity
and
Mo
rtal
ity
asso
ciat
ed w
ith
Vira
l Hep
atit
is
in V
icto
ria
(#13
8)
Che
lsea
Bro
wn
4.50
pm -
5.
30pm
Pane
l mem
bers
: Mic
hael
Nin
burg
, Ly
nnai
re M
atth
ews,
Sio
ne
Cra
wfo
rd, J
ack
Wal
lace
, Jilli
an
Whi
te, N
afisa
Yus
sf, a
nd R
osal
ie
Altu
s
5.00
pm -
5.
05pm
H
igh
Effica
cy o
f 8 W
eeks
Pa
rita
prev
ir/R
ito
navi
r/O
mbi
tasv
ir a
nd D
asab
uvir
am
ong
Peo
ple
wit
h R
ecen
t G
enot
ype
1 H
CV
Infe
ctio
n (#
29)
Mar
iann
e M
artin
ello
5.00
pm -
5.
15pm
C
ultu
ral a
nd L
ingu
isti
c D
iver
sity
o
f Peo
ple
Livi
ng w
ith
Chr
oni
c H
epat
itis
B, 2
011-
2016
: C
hang
ing
Mig
rati
on,
Shi
ftin
g Ep
idem
iolo
gy (#
121)
Jenn
ifer M
acLa
chla
n
5.05
pm -
5.
10pm
C
linic
ians
Att
itud
es T
owar
ds
the
Trea
tmen
t of P
atie
nts
wit
h H
epat
itis
C w
ho a
re In
ject
ing
Dru
g U
sers
(CAT
HPI
N) (
#99
)
Mar
y Fe
nech
5.15
pm -
5.
20pm
Dis
ease
Era
dica
tio
n –
The
Jo
urne
y T
hro
ugh
Big
Dat
a (#
46)
Gre
g Ro
yal
2 6
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
5.10
pm -
5.
15pm
T
EST
AN
D T
REA
T! –
A
Co
mm
unit
y B
ased
Vira
l H
epat
itis
Scr
eeni
ng a
nd
Trea
tmen
t Ser
vice
in a
Syd
ney
Bas
ed N
eedl
e an
d Sy
ring
e Pr
ogr
am (N
SP)
(#72
)
Virg
inia
McM
ahon
and
Lis
a D
owde
ll
5.20
pm -
5.
25pm
Hep
atit
is B
and
Imm
igra
tio
n in
A
ustr
alia
(#89
)
Zin
dia
Nan
ver
5.15
pm -
5.
20pm
Uti
liisi
ng A
So
cial
Net
wo
rk
Nur
se –
Led
Mo
del T
o E
ngag
e Pe
opl
e W
ho In
ject
Dru
gs in
th
e C
om
mun
ity
into
HC
V
Trea
tmen
t and
Car
e (#
93)
Jose
ph D
oyle
5.25
pm -
5.
30pm
Q&
A
5.20
pm -
5.
30pm
Q&
A
7.00
pmC
onf
eren
ce D
inne
r
Nat
iona
l Win
e C
entr
e
2 7
TU
ES
DA
Y, 1
4 A
UG
US
T 2
01
8
5.10
pm -
5.
15pm
T
EST
AN
D T
REA
T! –
A
Co
mm
unit
y B
ased
Vira
l H
epat
itis
Scr
eeni
ng a
nd
Trea
tmen
t Ser
vice
in a
Syd
ney
Bas
ed N
eedl
e an
d Sy
ring
e Pr
ogr
am (N
SP)
(#72
)
Virg
inia
McM
ahon
and
Lis
a D
owde
ll
5.20
pm -
5.
25pm
Hep
atit
is B
and
Imm
igra
tio
n in
A
ustr
alia
(#89
)
Zin
dia
Nan
ver
5.15
pm -
5.
20pm
Uti
liisi
ng A
So
cial
Net
wo
rk
Nur
se –
Led
Mo
del T
o E
ngag
e Pe
opl
e W
ho In
ject
Dru
gs in
th
e C
om
mun
ity
into
HC
V
Trea
tmen
t and
Car
e (#
93)
Jose
ph D
oyle
5.25
pm -
5.
30pm
Q&
A
5.20
pm -
5.
30pm
Q&
A
7.00
pmC
onf
eren
ce D
inne
r
Nat
iona
l Win
e C
entr
e
WE
DN
ES
DA
Y, 1
5 A
UG
US
T 2
01
8
8.00
amR
egis
trat
ion
ope
ns
8.30
am -
10
.00a
m
Pro
ffer
ed P
aper
s -
Tak
ing
Hep
atit
is C
Car
e to
the
Co
mm
unit
y an
d B
eyo
nd
Room
: Hal
l M | C
hairs
: Car
la G
orto
n an
d Ro
salie
Altu
s
8.30
am -
10
.00a
m
Pro
ffer
ed P
aper
s -
Spec
ialis
ed
wo
rk w
ith
iden
tifie
d co
mm
unit
ies
Room
: City
Roo
m 1
| Cha
irs:
Mel
anie
Wal
ker a
nd A
lex
Lam
pen-
Smith
8.30
am -
10
.00a
m
Pro
ffer
ed P
aper
s -
Sha
ring
in
nova
tio
ns in
Clin
ical
Car
e
Room
: City
Roo
m 2
| Cha
irs:
Sam
uel E
lliott
and
Ros
e M
agda
lene
8.30
am -
8.
45am
Eff
ecti
vene
ss a
nd A
ccep
tanc
e o
f an
Inte
nsiv
e S
cree
ning
and
C
ase
Find
ing
Inte
rven
tio
n in
a
Publ
ic O
TP
Clin
ic (#
328)
Jani
ce P
ritch
ard-
Jone
s
8.30
am-
8.45
am
A T
houg
htfu
l and
Co
llabo
rati
ve
App
roac
h to
Hep
atit
is B
is
Ess
enti
al w
hen
Wo
rkin
g in
Rem
ote
Abo
rigi
nal
Co
mm
unit
ies
(#11
7)
Paul
a Bi
nks
8.30
am-
8.45
am
Rea
l-W
orl
d O
utco
mes
of D
irec
t-A
ctin
g A
ntiv
iral T
hera
py fo
r C
hro
nic
Hep
atit
is C
Fo
llow
ing
Unr
estr
icte
d A
cces
s in
A
ustr
alia
: The
So
uth
Aus
tral
ian
Expe
rien
ce (#
57)
Jam
es H
arid
y
8.45
am -
9.
00am
An
Unm
et N
eed
for H
epat
itis
C
Tes
ting
at N
eedl
e an
d Sy
ring
e S
ervi
ces
– Le
sso
ns L
earn
ed
fro
m th
e Ra
pid-
EC F
easi
bilit
y St
udy
(#10
0)
Alis
a Pe
dran
a
8.45
am -
9.
00am
Part
neri
ng H
epat
olo
gy N
urse
s an
d Pe
er W
ork
ers
to In
crea
se
Trea
tmen
t am
ong
Mar
gina
lised
Pe
opl
e (#
87)
Kyle
Lea
dbea
tter
8.45
am -
9.
00am
Hep
atit
is C
Wo
rk-U
p A
nd
Trea
tmen
t: In
nova
tio
n In
C
orr
ecti
ona
l Nur
sing
Pra
ctic
e (#
9)
Susa
n O
'Nei
ll
9.00
am -
9.
15am
The
Cov
ert C
: Pre
vale
nce,
Ris
k Fa
cto
rs a
nd M
anag
emen
t of
Hep
atit
is C
Infe
ctio
n am
ong
Ps
ychi
atri
c In
-Pat
ient
s (#
36)
Jeya
man
i Ram
acha
ndra
n
9.00
am -
9.
15am
Supp
ort
ing
Pris
one
rs L
ivin
g w
ith
a B
loo
d B
orn
e V
irus
(#4)
Emm
a W
illiam
s
9.00
am -
9.
15am
Nev
er F
ear P
enca
t Is
Her
e -
A N
atio
nally
Ava
ilabl
e To
ol F
or C
hro
nic
Hep
atit
is
B M
anag
emen
t In
Gen
eral
Pr
acti
ce (#
61)
Lisa
Dow
dell
2 8
WE
DN
ES
DA
Y, 1
5 A
UG
US
T 2
01
8
9.15
am -
9.
30am
Elim
inat
ion
of H
epat
itis
C
in N
SW
Pri
sons
: Po
ssib
le o
r Po
intl
ess?
The
Exp
erie
nce
of J
usti
ce H
ealt
h &
Fo
rens
ic
Men
tal H
ealt
h N
etw
ork
Tw
o
Yea
rs A
fter
the
Intr
odu
ctio
n o
f N
ew C
urat
ive
Trea
tmen
ts (#
79)
Col
ette
McG
rath
9.15
am -
9.
30am
The
So
cial
Ben
efits
of
Succ
essf
ul D
AA
The
rapy
B
eyo
nd C
ure:
A S
truc
tura
l C
om
pete
ncy
App
roac
h (#
97)
Car
la T
relo
ar
9.15
am -
9.
30am
Adh
eren
ce a
nd V
irolo
gica
l O
utco
mes
for H
epat
itis
B
Ant
ivira
l The
rapy
am
ong
st
Indi
geno
us A
ustr
alia
ns in
the
Rem
ote
Top
End,
No
rthe
rn
Ter
rito
ry (#
144)
Car
olin
e Le
e
9.30
am -
9.
35am
H
epat
itis
C In
The
ED
-
Scr
eeni
ng F
or H
epat
itis
C
Infe
ctio
n in
the
Ho
spit
al
Emer
genc
y D
epar
tmen
t usi
ng
Poin
t-O
f-C
are
Tes
ting
(#92
)
Ale
x T
hom
pson
9.30
am -
9.
35am
A
rt In
side
: Eng
agin
g Pr
iso
ners
In
Vira
l Hep
atit
is (
#33
)
Ste
ven
Tayl
or
9.30
am -
9.
35am
R
ecal
l Can
Incr
ease
Tre
atm
ent
Upt
ake:
An
Aud
it o
f Po
siti
ve
Hep
atit
is C
PC
R T
ests
at t
he
Kir
keto
n Ro
ad C
entr
e (#
42)
Rebe
cca
Loth
ian
9.35
am -
9.
40am
H
epat
itis
C V
irus
(HC
V) T
esti
ng,
Live
r Dis
ease
Ass
essm
ent
and
Dir
ect-
Act
ing
Ant
ivira
l (D
AA
) Tre
atm
ent U
ptak
e an
d O
utco
mes
in a
Ho
mel
ess
Ser
vice
in S
ydne
y: T
he L
iver
life
Stud
y (#
10)
Saha
r Baj
is
9.35
am -
9.
40am
Ex
plo
ring
The
Acc
epta
bilit
y O
f Po
int-
Of-
Car
e H
epat
itis
C
Tes
ting
Fo
r Peo
ple
Who
Inje
ct
Dru
gs: A
Qua
litat
ive
Ana
lysi
s
(#10
7)
Alis
a Pe
dran
a
9.35
am -
9.
40am
Q
uiet
Ach
ieve
rs –
A M
ulti
-D
isci
plin
ary
App
roac
h to
HC
V
Trea
tmen
t and
Man
agem
ent i
n M
argi
nalis
ed P
opu
lati
ons
– T
he
QuI
HN
Out
reac
h M
ode
l (#
96)
Mar
y Fe
nech
9.40
am -
9.
45am
Po
int o
f Car
e Ra
pid
HC
V
Ant
ibo
dy T
esti
ng o
f Nee
dle
Exch
ange
Clie
nts:
Res
ults
fro
m
a N
ew Z
eala
nd P
ilot S
tudy
(#7)
Geo
ff N
olle
r
9.40
am -
9.
45am
Li
verB
ette
rLife
: Hep
atit
is
C T
reat
men
t Aw
aren
ess
Cam
paig
n in
Rur
al S
out
h A
ustr
alia
(#66
)
Nic
ole
Tayl
or
9.40
am -
9.
45am
Im
plem
enta
tio
n o
f a H
osp
ital
-Le
d, C
om
mun
ity
Bas
ed,
Hep
ato
logy
Nur
se P
ract
itio
ner
Mo
del o
f Car
e in
an
Inne
r-C
ity
Sydn
ey S
etti
ng (#
132)
Sine
ad S
heils
2 9
WE
DN
ES
DA
Y, 1
5 A
UG
US
T 2
01
8
9.15
am -
9.
30am
Elim
inat
ion
of H
epat
itis
C
in N
SW
Pri
sons
: Po
ssib
le o
r Po
intl
ess?
The
Exp
erie
nce
of J
usti
ce H
ealt
h &
Fo
rens
ic
Men
tal H
ealt
h N
etw
ork
Tw
o
Yea
rs A
fter
the
Intr
odu
ctio
n o
f N
ew C
urat
ive
Trea
tmen
ts (#
79)
Col
ette
McG
rath
9.15
am -
9.
30am
The
So
cial
Ben
efits
of
Succ
essf
ul D
AA
The
rapy
B
eyo
nd C
ure:
A S
truc
tura
l C
om
pete
ncy
App
roac
h (#
97)
Car
la T
relo
ar
9.15
am -
9.
30am
Adh
eren
ce a
nd V
irolo
gica
l O
utco
mes
for H
epat
itis
B
Ant
ivira
l The
rapy
am
ong
st
Indi
geno
us A
ustr
alia
ns in
the
Rem
ote
Top
End,
No
rthe
rn
Ter
rito
ry (#
144)
Car
olin
e Le
e
9.30
am -
9.
35am
H
epat
itis
C In
The
ED
-
Scr
eeni
ng F
or H
epat
itis
C
Infe
ctio
n in
the
Ho
spit
al
Emer
genc
y D
epar
tmen
t usi
ng
Poin
t-O
f-C
are
Tes
ting
(#92
)
Ale
x T
hom
pson
9.30
am -
9.
35am
A
rt In
side
: Eng
agin
g Pr
iso
ners
In
Vira
l Hep
atit
is (
#33
)
Ste
ven
Tayl
or
9.30
am -
9.
35am
R
ecal
l Can
Incr
ease
Tre
atm
ent
Upt
ake:
An
Aud
it o
f Po
siti
ve
Hep
atit
is C
PC
R T
ests
at t
he
Kir
keto
n Ro
ad C
entr
e (#
42)
Rebe
cca
Loth
ian
9.35
am -
9.
40am
H
epat
itis
C V
irus
(HC
V) T
esti
ng,
Live
r Dis
ease
Ass
essm
ent
and
Dir
ect-
Act
ing
Ant
ivira
l (D
AA
) Tre
atm
ent U
ptak
e an
d O
utco
mes
in a
Ho
mel
ess
Ser
vice
in S
ydne
y: T
he L
iver
life
Stud
y (#
10)
Saha
r Baj
is
9.35
am -
9.
40am
Ex
plo
ring
The
Acc
epta
bilit
y O
f Po
int-
Of-
Car
e H
epat
itis
C
Tes
ting
Fo
r Peo
ple
Who
Inje
ct
Dru
gs: A
Qua
litat
ive
Ana
lysi
s
(#10
7)
Alis
a Pe
dran
a
9.35
am -
9.
40am
Q
uiet
Ach
ieve
rs –
A M
ulti
-D
isci
plin
ary
App
roac
h to
HC
V
Trea
tmen
t and
Man
agem
ent i
n M
argi
nalis
ed P
opu
lati
ons
– T
he
QuI
HN
Out
reac
h M
ode
l (#
96)
Mar
y Fe
nech
9.40
am -
9.
45am
Po
int o
f Car
e Ra
pid
HC
V
Ant
ibo
dy T
esti
ng o
f Nee
dle
Exch
ange
Clie
nts:
Res
ults
fro
m
a N
ew Z
eala
nd P
ilot S
tudy
(#7)
Geo
ff N
olle
r
9.40
am -
9.
45am
Li
verB
ette
rLife
: Hep
atit
is
C T
reat
men
t Aw
aren
ess
Cam
paig
n in
Rur
al S
out
h A
ustr
alia
(#66
)
Nic
ole
Tayl
or
9.40
am -
9.
45am
Im
plem
enta
tio
n o
f a H
osp
ital
-Le
d, C
om
mun
ity
Bas
ed,
Hep
ato
logy
Nur
se P
ract
itio
ner
Mo
del o
f Car
e in
an
Inne
r-C
ity
Sydn
ey S
etti
ng (#
132)
Sine
ad S
heils
WE
DN
ES
DA
Y, 1
5 A
UG
US
T 2
01
8
9.45
am -
9.
50am
W
hen
Hep
C C
are
& T
reat
men
t M
eets
NS
P… It
s Po
siti
vely
Hep
(#
40)
Julie
Pag
e
9:45
am -
9.
50am
Fa
r No
rth
Que
ensl
and
Live
r H
ealt
h C
ham
pio
ns (#
85)
Mor
gan
Dem
psey
9.45
am -
10
.00a
mQ
&A
9.50
am -
10
.00a
mQ
&A
9.50
am -
9.
55am
Q
uIH
N T
owns
ville
TM
P: A
Fl
exib
le A
ppro
ach
to O
ffer
ing
Hep
atit
is C
Tre
atm
ent (
#11
2)
Julie
-ann
Mar
kham
9.55
am -
10
.00a
mIn
crea
sing
Hep
atit
is C
Tes
ting
an
d Tr
eatm
ent a
mo
ng S
exua
lly
Adv
entu
rous
Men
Who
Hav
e S
ex w
ith
Men
(#1)
Lore
n Br
ener
10.0
0am
-
10.3
0am
M
orn
ing
Tea
Room
: Exh
ibiti
on H
all L
10.3
0am
-
12.0
0pm
Clo
sing
Ple
nary
- B
e In
form
ed
Room
: Hal
l M | C
hairs
: Car
la T
relo
ar a
nd B
enja
min
Cow
ie
10.3
0am
-
10.4
0am
H
epat
itis
B L
ived
exp
erie
nce
spea
ker
10.4
0am
-
10.5
0am
N
o O
ne L
eft B
ehin
d: T
he C
ase
for S
tren
gthe
ning
Hea
lth
Info
rmat
ion
Man
agem
ent S
yste
ms
Mic
hael
Lar
kin,
Blo
od B
orne
Viru
s Pr
ogra
m C
oord
inat
or, A
borig
inal
Hea
lth C
ounc
il of S
outh
Aus
tral
ia, S
A, A
ustr
alia
3 0
WE
DN
ES
DA
Y, 1
5 A
UG
US
T 2
01
8
10.5
0am
-
11.5
0am
Pa
nel D
iscu
ssio
n -
You
CA
N a
sk th
at
Faci
litat
ors:
Car
la T
relo
ar a
nd B
enja
min
Cow
ie
Clin
ical
and
Hea
lth W
orke
r Pan
el: D
r Vic
toria
Coc
k, D
r Jill
Bens
on, D
r Ale
x La
mpe
n-Sm
ith, M
icha
el L
arki
n an
d M
ary
Fene
ch
Peop
le w
ith L
ived
Exp
erie
nce
Pane
l: N
afisa
Yus
sf, Y
vonn
e D
razi
c, L
isa
Car
ter,
Car
ol H
olly,
Sio
ne C
raw
ford
11.5
0am
-
12.0
0pm
Co
nfer
ence
Clo
sing
rem
arks
Ale
xis
Apo
stol
ellis
, Chi
ef E
xecu
tive
Offi
cer,
The
Aus
tral
asia
n So
ciet
y fo
r HIV
, Vira
l Hep
atiti
s an
d Se
xual
Hea
lth M
edic
ine,
NSW
, Aus
tral
ia
12.0
0pm
C
onf
eren
ce c
lose
3 1
P O ST E R L I ST I N G
Poster Title First Name Last Name
CO M M U N I T Y & S O C I A L R E S E A R C H
1 Hepatitis C - Reaching The High Hanging Fruit: The Test Cure Live Initiative
Wendy Anderson
2 Look After Your Blood – Developing A Blood-Borne Virus Social Marketing Campaign For Young Aboriginal People
Judith Bevan
3 Reorientation Of Hepatitis C Services In Victoria Elizabeth Birbilis
4 A Community Based Model Of Care For Migrants And Refugees With Viral Hepatitis, At The Ethnic Communities Council Of Queensland (ECCQ).
Marrianne Black
5 Community Conversations With People Who Inject Drugs In Southern Sydney
Tracey Brown
6 Peer Insights: Understanding Motivators And Barriers To The Uptake Of Hepatitis C Treatments Among People Who Inject Drugs
Susan Chong
7 Removing Barriers To Testing For People: Pre-Paid, Flexible And Hasle Free
Timothy Duck
8 Blood-Borne Virus Prevention And Blood Awareness Among Men Who Inject Performance And Image Enhancing Drugs
Renae Fomiatti
9 Short And Simple Messages Are Not Enough – Developing A Resource For People Living With Chronic Hepatitis B From Non-English Speaking Backgrounds
Zhihong Gu
10 Reaching Out To The Chinese Community Zhihong Gu
11 Working Together The ‘Korean Health Expo’ Increases Awareness Of Hepatitis B And General Health Issues And Services Amongst The Korean Community
Mina Kim
12 Qualitative Needs Assessment Investigating The Information And Support Needs Of People With Hepatitis B And Hepatitis C In The ACT
Kerrie Mckenzie
13 Increasing Capacity To Work Effectively With Young People At Risk Of Hepatitis C
Virginia McMahon
3 2
Poster Title First Name Last Name
14 Barriers And Help-Seeking Practices: Perspectives Of South Sudanese People With Chronic Hepatitis B In Australia
William Mude
15 GUD WUN POR PLES | Communities Creating for Community: A Sustainable Resource Project
Samantha White
16 How Do We Reach The Other 75% Of People With Untreated Chronic Hepatitis C?
Leanne Myers
17 Barriers to Eradicating Hep C Joss O'Loan
18 Hepatitis B Needs Assessment For Afghani Community In South Australia
Enaam Oudih
19 “Hep B: Could It Be Me? An Inclusive Communications Strategy Promoting Testing For Hepatitis B Testing In Diverse Communities
Sonam Paljor
20 LiverWELL: An Interactive Mobile App for Liver Health Management
Mark Pearce
21 “We Belong”- A Peer Based Review On Extension, Inclusion And Appropriateness Of Health Care In The Multicultural Communities.
Anup Pereira
22 Mobilisation Of CALD Communities Around Sensitive Issues
Wael Sabri
23 HEPready: An Innovative Model For Viral Hepatitis Workforce Development
Kate Webster
24 The Narrowest Point: Hepatitis C in Remand Mary O’Flynn
E P I D E M I O LO GY, P U B L I C H E A LT H & P R E V E N T I O N
25 Hepatitis D: Epidemiology In South Australia 2005-2014 Anushia Ashokan
26 Seroprevalence And Risk Factors Of Hepatitis E Among Population Aged 15- 49 Years: A Cross Sectional Study In Regional Locality, Sudan
HibaWITHDRAWN
AzragWITHDRAWN
27 Initiations Of New Direct Acting Antiviral (DAA) Treatment For Chronic Hepatitis C (HCV) In Western Australia (WA): A Review Of The First Year
Jude Bevan
3 3
Poster Title First Name Last Name
28 Hepatitis B – A Systems Approach To Reduce Hepatitis B Infections In NSW
Timothy Duck
29 Hepatitis C Elimination In Nsw By 2028 - Priming The System To Deliver Equity In NSW
Timothy Duck
30 Implementation Of An Online Workforce Development Program For Community Pharmacists
Nicole Gunn
31 Evaluation of the Impact of Hepatitis B s100 Community Prescribing in Australia
Katelin Haynes
32 Hepatitis C Knowledge, Readiness For Treatment, Subsequent Patient Experience And Side Effects Of Direct Acting Antivirals (DAA) In Clients Attending A Drug And Alcohol Clinic.
Xiu Qin Lim
33 Barriers And Facilitators To Diagnosis And Treatment Commencement And Completion Among First Nations People Living With Hepatitis C Virus (HCV)
Emily Phillips
34 Elements Of Community-Based Models Of Care For Treating Hepatitis C
Davoud Pourmarzi
35 Monitoring The Elimination Of Mother-To-Child Transmission Of Hepatitis B In Australia
Nicole Romero
36 Epidemiologic Trends In Viral Hepatitis Notifications In Australia, 1996-2016
Laura Thomas
37 Hepatitis B Status Is Significantly Associated With Sexually Transmissible Infection Positivity – A Case Controlled Study At A Publicly Funded Sexual Health Service In Sydney, Australia
Rick Varma
38 Evaluation Of An Integrated Nurse Model Of Care Providing Hepatitis C Treatment To People Attending Homeless Services In Melbourne, Australia
Bradley Whitton
S C I E N C E A N D C L I N I C A L C A R E
39 Viral Hepatitis - A Paediatric Experience Brooke Andersen
40 Analysis Of The Lipidome In Chronic Hepatitis C Virus (HCV) Shows Genotypic Differences Which Resolve With Viral Clearance
Margaret Bassendine
41 Towards Elimination - Increasing Access and Expediting Hepatitis C Treatment in a Rural Correctional Facility
Melany Day
3 4
Poster Title First Name Last Name
42 Impact Of Acid-Reducing Agents On Effectiveness Of Elbasvir/Grazoprevir In Treating Us Veterans Affairs Population With Hepatitis C Virus
Adrian Desfontaines
43 Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients with Chronic Hepatitis C Genotypes 1–6 and Recent Drug Use.
Gregory Dore
44 Outcomes Of Community-Based Hepatitis C Treatment Using An Ehealth Model Of Care
James Haridy
45 Nurses role when the Hepatitis C is cured but the Cirrhosis remains
Janice Pritchard-Jones
46 The Prevalence of Serum Hepatitis B Surface Antibody (HBVsAb) < 10 IU/L in Hepatitis C PCR Positive Patients in Two Large Specialist General Practices in South East Queensland (Bris/Gold Coast).
Gary Keogh
47 Effectiveness And Utilization Of Elbasvir/Grazoprevir In Hcv Genotype 1 And 4 Infection In The Veteran Affairs Healthcare System In The United States
Susila Kulasingam
48 Deep Sequencing Analysis Of Hbv Isolated From Patient Samples During A Treatment Cessation Trial.
Margaret Littlejohn
49 Difficult Venous Access: Addressing This Barrier To Care In Hepatitis Treatment Clinics
Susan Mason
50 Engaging Hard To Reach Populations With Hepatitis C; The New Zealand Central Region Experience.
Lynnaire Matthews
51 Hepatitis C: Towards Elimination in Community Opiate Treatment Programs, Bathurst Regional Hub.
Katherine McQuillan
52 Enabling Hepatitis C (HCV) Treatment In Primary Care Through Community Based Fibroscan Assessment Clinics
James O'Beirne
53 FIB-4 Is Highly Efficient At Excluding Cirrhosis In HCV -Validation Of A New Cut Off
James O'Beirne
54 Efficacy And Safety Of Elbasvir/Grazoprevir In Women Infected With Hepatitis C Virus Genotype 1 Or 4 And Co-Administered Oral Contraceptives Or Hormone Replacement Therapy
Stefan Orange
55 Global Scientific Strategy For An HBV Cure Peter Revill
3 5
Poster Title First Name Last Name
56 Retrospective Analysis Of A Clinical Waitlist For Hepatitis C Treatment With All Oral Therapy In The Hunter New England Local Health District: Is The Warehouse Empty?
Suresh Sharma
57 In Vitro Studies Identify A Low Replication Phenotype For Hepatitis B Virus Genotype H Generally Associated With Less Severe Liver Disease
Vitini Sozzi
58 “CURE IT” Program- Curing Hepatitis C (HCV) Whilst Avoiding Hospital Attendance.
Hayley Thompson
59 Nursing Model Of Care For Chronic Hepatitis B, In The Community - New Zealand, Explained. Explained by Hepatitis & Fibroscan Nurse of The Hepatitis Foundation NZ.
Jillian White
60 Increasing Access To Hepatitis C Virus (HCV) Direct Acting Antivirals (DAAS) For South City Drug And Alcohol And Psychiatry Outpatients Of The Alfred Hospital Melbourne
Bradley Whitton
3 6M
onda
y 5
- Tu
esda
y 6
Aug
ust
2019
Ple
ase
mar
k th
e d
ates
fo
r th
e A
ustr
alas
ian
Vir
al H
epat
itis
Elim
inat
ion
Co
nfer
ence
20
19
in y
our
dia
ry a
nd s
hare
thi
s in
form
atio
n
wit
h co
lleag
ues.
Abs
trac
t D
eadl
ine:
7 A
pri
l 20
19
Earl
y B
ird
Reg
istr
atio
n: 2
6 M
ay 2
019
Acc
omm
odat
ion:
31
June
20
19
Stan
dard
Reg
istr
atio
n: 2
1 Ju
ly 2
019
AV
HE
C C
onf
eren
ce S
ecre
tari
atP:
+61
2 8
204
077
0F:
+61
2 8
204
077
9E:
info
@av
hec2
019
.co
mw
ww
.avh
ec20
19.c
om
Aus
tral
asia
n V
iral
Hep
atit
is
Elim
inat
ion
Con
fere
nce
2019
3 7
Mon
day
5 -
Tues
day
6 A
ugus
t 20
19
Ple
ase
mar
k th
e d
ates
fo
r th
e A
ustr
alas
ian
Vir
al H
epat
itis
Elim
inat
ion
Co
nfer
ence
20
19
in y
our
dia
ry a
nd s
hare
thi
s in
form
atio
n
wit
h co
lleag
ues.
Abs
trac
t D
eadl
ine:
7 A
pri
l 20
19
Earl
y B
ird
Reg
istr
atio
n: 2
6 M
ay 2
019
Acc
omm
odat
ion:
31
June
20
19
Stan
dard
Reg
istr
atio
n: 2
1 Ju
ly 2
019
AV
HE
C C
onf
eren
ce S
ecre
tari
atP:
+61
2 8
204
077
0F:
+61
2 8
204
077
9E:
info
@av
hec2
019
.co
mw
ww
.avh
ec20
19.c
om
Aus
tral
asia
n V
iral
Hep
atit
is
Elim
inat
ion
Con
fere
nce
2019
3 8
w w w . h e p a t i t i s . o r g . a u
